ATI LPN
Medical Surgical ATI Proctored Exam Questions
Question 1 of 5
A client with a diagnosis of schizophrenia is being treated with risperidone (Risperdal). Which finding should the nurse report to the healthcare provider immediately?
Correct Answer: C
Rationale: The correct answer is C: Muscle rigidity. This finding could be indicative of Neuroleptic Malignant Syndrome (NMS), a rare but serious side effect of antipsychotic medications like risperidone. NMS is characterized by severe muscle rigidity, fever, altered mental status, and autonomic dysfunction. Prompt medical intervention is crucial to prevent complications. A: Weight gain is a common side effect of risperidone and is typically not considered an urgent issue. B: Dry mouth is a common side effect of risperidone and can be managed with oral hygiene measures. D: Drowsiness is a common side effect of risperidone and may improve over time or with dosage adjustments. It is not typically an immediate concern unless severe or accompanied by other worrisome symptoms.
Question 2 of 5
A client with rheumatoid arthritis is prescribed methotrexate. Which instruction should the nurse include in the client's teaching?
Correct Answer: A
Rationale: The correct answer is A: Avoid alcohol while taking this medication. Methotrexate can cause liver toxicity, and alcohol consumption can exacerbate this risk. It is important for the client to avoid alcohol to prevent potential harm to the liver. B: Taking the medication with a full meal is not a necessary instruction for methotrexate. It is typically recommended to take methotrexate on an empty stomach. C: Increasing intake of high-fiber foods is not directly related to methotrexate therapy. It is important for overall health but not specifically for this medication. D: Avoiding exposure to sunlight is not a common instruction for methotrexate. While some medications can increase sensitivity to sunlight, this is not a typical concern with methotrexate.
Question 3 of 5
A client is being treated with an antidepressant for major depressive disorder. Which statement by the client indicates a need for further teaching?
Correct Answer: C
Rationale: Correct Answer: C Rationale: 1. Stopping medication abruptly can lead to withdrawal symptoms and a potential relapse of depressive symptoms. 2. The client should be educated on the importance of completing the full course of treatment. 3. This statement indicates a lack of understanding regarding the need for continued medication adherence. 4. Choices A, B, and D are all appropriate and demonstrate good understanding of antidepressant treatment.
Question 4 of 5
A client with a history of atrial fibrillation is prescribed dabigatran (Pradaxa). Which instruction should the nurse include in the client's teaching?
Correct Answer: C
Rationale: The correct answer is C: Take the medication at the same time each day. This instruction is crucial for maintaining consistent blood levels of dabigatran, maximizing its effectiveness in preventing blood clots. Taking it at the same time each day helps establish a routine and reduces the risk of missed doses. Choice A is incorrect because dabigatran should be taken without regard to meals. Choice B is incorrect as vitamin K does not interact with dabigatran. Choice D is incorrect because increasing high-potassium foods is not necessary for dabigatran therapy.
Question 5 of 5
A client with a history of deep vein thrombosis (DVT) is receiving warfarin (Coumadin). Which laboratory value indicates a therapeutic effect of the medication?
Correct Answer: A
Rationale: The correct answer is A: INR of 2.5. INR (International Normalized Ratio) is used to monitor the effectiveness of warfarin therapy. A target INR range for DVT treatment is typically 2.0-3.0. An INR of 2.5 indicates that the client's blood is clotting within the desired therapeutic range, preventing excessive clotting while avoiding excessive bleeding. B: PTT measures the effectiveness of heparin, not warfarin. C: Hemoglobin level and D: Platelet count are not specific indicators of warfarin's therapeutic effect on clotting factors. In summary, the correct answer A is the most relevant laboratory value for monitoring the therapeutic effect of warfarin in a client with DVT.